Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group None., (2023), The lancet. Diabetes & endocrinology, 11, 905 - 914

Effects of Empagliflozin on Fluid Overload, Weight and Blood Pressure in Chronic Kidney Disease

Journal article

Mayne K. et al, (2023), Journal of the American Society of Nephrology

Delivering trials in the NHS: more than worth it.

Journal article

Haynes R. et al, (2023), Clinical medicine (London, England), 23, 525 - 526

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.

Journal article

Inker LA. et al, (2023), Nature medicine

Reliability of major bleeding events in UK routine data versus clinical trial adjudicated follow-up data.

Journal article

Harper C. et al, (2023), Heart (British Cardiac Society)

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.

Journal article

RECOVERY Collaborative Group. Electronic address: recoverytrial@ndph.ox.ac.uk None. and RECOVERY Collaborative Group None., (2023), Lancet (London, England), 401, 1499 - 1507

Fast tracking informative clinical trials: lessons for mental health.

Journal article

Gold SM. et al, (2023), Lancet Psychiatry

Facilitating participation in clinical trials during pregnancy.

Journal article

Vousden N. et al, (2023), BMJ, 380

A Pragmatic Randomized Feasibility Trial of Influenza Vaccines

Journal article

Johansen ND. et al, (2023), NEJM Evidence, 2

Empagliflozin in Patients with Chronic Kidney Disease.

Journal article

EMPA-KIDNEY Collaborative Group None. et al, (2022), The New England journal of medicine

Load More